Nephrology News

Researchers from Icahn School of Medicine at Mount Sinai found a machine-learning model performed well in predicting risk for AKI and need for dialysis in patients hospitalized with COVID-19.

Study findings suggest Black and Hispanic patients are at greater risk for developing kidney failure due to faster decline in kidney function following chronic kidney disease onset vs. white patients.

Results of a survey administered to members of the American Nephrology Nurses Association showed many experienced a high workload which, according to two speakers, may contribute to decreased well-being, along with staffing challenges.

An approach that uses artificial intelligence by including cardiac biomarkers into a machine learning algorithm more accurately predicted atrial fibrillation in patients with chronic kidney disease than use of a previously published model.

A study of U.S. kidney transplant recipients showed no significant changes in cancer incidence during a period of 3 decades, with rates of graft failure and mortality remaining high.

A study of living kidney donors in Denmark found that while donation was associated with a greater risk for hypertension, it did not appear to increase the likelihood of donors developing cardiovascular disease.

Along with close monitoring, incorporating “fad diets” into more evidence-based weight loss approaches may improve outcomes for patients with kidney disease, according to a former dialysis dietician who now works in CKD research.

Obinutuzumab provides sustained clinical benefit through 2 years among patients with lupus nephritis, with treatment efficacy maintained 18 months after the final infusion, according to data presented at ACR 2020.

Dapagliflozin reduced the worsening of kidney function and the risk of cardiovascular or renal death in patients with chronic kidney disease irrespective of the underlying cause of kidney disease, according to recently presented data.

Though contending the care currently provided to patients is “poor,” a speaker at ASN Kidney Week said society is at a “uniquely positive sweet-spot” in which vascular access care, as well as kidney care as a whole, can be transformed.